Strides Pharma
- All
- News
- Videos
-
Anti-Covid Pill Soon As Drug Regulator Approves Emergency Use
With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio
-
Stocks To Watch: Coal India, Strides Pharma, NHPC, Jaiprakash Power Ventures
Coal India reported a 0.8 per cent decline in consolidated profit to Rs 4,588.96 crore in the quarter ended March 2021 from Rs 4,625.7 crore in the same quarter ended last year
-
Strides Pharma Gets Nod For Prednisone Tablets; Stock Sheds Over 1%
Strides Pharma: Prednisone drugs, also known as corticosteroids, are used as anti-inflammatory and immuno-suppressant medications for treating allergic disorders, skin conditions, ulcerative colitis and arthritis.
-
Strides Pharma Surges On USFDA Nod For Headache Drug
Strides Pharma shares surged as much as 5% after it got approval from USFDA for Butalbital, Acetaminophen, Caffeine, andCodeine Phosphate Capsules.
-
Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients
The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.
-
Strides Pharma To Conduct Trials In India For Potential COVID-19 Drug
Bengaluru-based Strides Pharma Science has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country.
-
Strides Pharma Surrenders Early Gains To End Lower On News Of Developing Antivirals For Covid-19
Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.
-
Glenmark Pharma To Conduct Trials For Potential COVID-19 Drug, Shares Jump
Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.
-
Buy Strides Pharma Science, HDFC Bank August Futures, Says Choice Broking
After a healthy correction from its all-time high, the Nifty has managed to take a support at its 100 weeks moving average which indicates a bounce back move in the Index.
-
Why Shares Of This Bengaluru-Based Drug Maker Plunged Over 8% Today
US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.
-
Strides Shasun Gets USFDA Go-Ahead For Anti-Allergy Drug
Citing IMS sales data, Strides Shasun said the US market for the approved product is approximately $17 million.
-
Strides Shasun R&D Unit Gets US Health Regulator's Closure Report
Shares of Strides Shasun were trading at Rs 1,077 apiece, up 0.13 per cent, from its previous close on the BSE
-
Strides Gets US Regulator's Nod For Constipation Drug
Strides Shasun on Thursday said it has received approval from the US Food and Drug Administration (FDA) for Polyethylene Elycol 3350, used for treating constipation.
-
Strides Shasun Gets US Regulator's Nod For Intestinal Ulcer Drug
Strides Shasun on Wednesday said it has received approval from the US Food and Drug Administration (FDA) for Ranitidine tablets used for treating intestinal and stomach ulcers and gastroesophageal reflux disease.
-
Strides Shasun Completes Acquisition Of Australia's Generic Partners
Drug firm Strides Shasun on Wednesday said it has completed acquisition of a controlling stake in Australia-based Generic Partners Holdings.
-
Anti-Covid Pill Soon As Drug Regulator Approves Emergency Use
With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio
-
Stocks To Watch: Coal India, Strides Pharma, NHPC, Jaiprakash Power Ventures
Coal India reported a 0.8 per cent decline in consolidated profit to Rs 4,588.96 crore in the quarter ended March 2021 from Rs 4,625.7 crore in the same quarter ended last year
-
Strides Pharma Gets Nod For Prednisone Tablets; Stock Sheds Over 1%
Strides Pharma: Prednisone drugs, also known as corticosteroids, are used as anti-inflammatory and immuno-suppressant medications for treating allergic disorders, skin conditions, ulcerative colitis and arthritis.
-
Strides Pharma Surges On USFDA Nod For Headache Drug
Strides Pharma shares surged as much as 5% after it got approval from USFDA for Butalbital, Acetaminophen, Caffeine, andCodeine Phosphate Capsules.
-
Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients
The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.
-
Strides Pharma To Conduct Trials In India For Potential COVID-19 Drug
Bengaluru-based Strides Pharma Science has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country.
-
Strides Pharma Surrenders Early Gains To End Lower On News Of Developing Antivirals For Covid-19
Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.
-
Glenmark Pharma To Conduct Trials For Potential COVID-19 Drug, Shares Jump
Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.
-
Buy Strides Pharma Science, HDFC Bank August Futures, Says Choice Broking
After a healthy correction from its all-time high, the Nifty has managed to take a support at its 100 weeks moving average which indicates a bounce back move in the Index.
-
Why Shares Of This Bengaluru-Based Drug Maker Plunged Over 8% Today
US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.
-
Strides Shasun Gets USFDA Go-Ahead For Anti-Allergy Drug
Citing IMS sales data, Strides Shasun said the US market for the approved product is approximately $17 million.
-
Strides Shasun R&D Unit Gets US Health Regulator's Closure Report
Shares of Strides Shasun were trading at Rs 1,077 apiece, up 0.13 per cent, from its previous close on the BSE
-
Strides Gets US Regulator's Nod For Constipation Drug
Strides Shasun on Thursday said it has received approval from the US Food and Drug Administration (FDA) for Polyethylene Elycol 3350, used for treating constipation.
-
Strides Shasun Gets US Regulator's Nod For Intestinal Ulcer Drug
Strides Shasun on Wednesday said it has received approval from the US Food and Drug Administration (FDA) for Ranitidine tablets used for treating intestinal and stomach ulcers and gastroesophageal reflux disease.
-
Strides Shasun Completes Acquisition Of Australia's Generic Partners
Drug firm Strides Shasun on Wednesday said it has completed acquisition of a controlling stake in Australia-based Generic Partners Holdings.
